First-Trimester Intrauterine Hematoma and Outcome of Pregnancy

Department of Obstetrics and Gynecology, IRCCS Burlo Garofolo, University of Trieste, Via dell'Istria 65, I-34137 Trieste, Italy.
Obstetrics and Gynecology (Impact Factor: 5.18). 03/2005; 105(2):339-44. DOI: 10.1097/
Source: PubMed


To evaluate the outcome of pregnancies complicated by first-trimester intrauterine hematoma.
An analysis was performed on 248 cases. The pregnancy outcome was correlated with hematoma volume, gestational age (weeks), and maternal age (years).
One hundred eighty-two cases were eligible for the study. Clinical complications occurred in 38.5% of the cases (adverse outcome group). Spontaneous abortion (14.3%), fetal growth restriction (7.7%), and preterm delivery (6.6%) were the most frequent clinical conditions observed. Considering the hematoma variables in adverse and favorable outcome groups, we found a significant difference only for gestational age at diagnosis. The median gestational age was significantly lower (P < .02) in the adverse outcome group (7.27, I and III quartiles 6.22-8.78) than in the favorable outcome cases (8.62, I and III quartiles 6.70-9.98). Among clinical conditions, the median gestational age was significantly lower (P = .02) in pregnancies complicated by spontaneous abortion (6.60, I and III quartiles 5.95-8.36) than in cases not ending in a miscarriage (8.50, I and III quartiles 6.70-9.91). The overall risk of adverse outcome was 2.4 times higher when the hematoma was diagnosed before 9 weeks (odds ratio 2.37, 95% confidence interval 1.20-4.70). In particular, intrauterine hematoma observed before 9 weeks significantly increases the risk of spontaneous abortion (odds ratio 14.79, 95% confidence interval 1.95-112.09)
Intrauterine hematoma can affect the outcome of pregnancy. The risk of spontaneous abortion is related to gestational age and is significantly increased if diagnosed before 9 weeks.

Download full-text


Available from: Gianpaolo Maso, Feb 16, 2015

  • No preview · Article · May 2006 · FMC - Formación Médica Continuada en Atención Primaria
  • [Show abstract] [Hide abstract]
    ABSTRACT: The early human embryo develops in a tightly controlled, relatively protected environment. During the first 8–12 weeks of human gestation, the delivery of maternal blood, and therefore the amount of oxygen to the developing embryo is limited and the embryo is supplied with essential nutrients in part via the decidual uterine glands, the placental trophoblast and the secondary yolk sac. Factors that interfere with this process may well result in spontaneous miscarriage or adverse outcome later in pregnancy. There is mounting evidence for the presence of transporter systems for many substances including drugs and toxins from the maternal to the fetal compartments in early pregnancy. The role of these substances in both the protection of early pregnancy development and possible teratogenicity are explored in this chapter. Clearly, the timing of exposure to potentially damaging substances is crucial with effects on conception, implantation, placental development and organogenesis dependent on the gestation at which exposure occurs.
    No preview · Article · Sep 2006 · Reviews in Gynaecological and Perinatal Practice
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: According to our knowledge the safety of chorionic villus sampling (CVS) has not been studied in the presence of subchorionic hematoma (SCH). Our study aimed to evaluate the effects of CVS on the procedure-related fetal loss rate in patients with SCH. Method: Fifty-six patients with asymptomatic SCH (cases) and 986 controls in whom there was no hematoma underwent elective CVS for a prenatal diagnosis of β-thalassemia and were entered into a prospective study. Mean gestational age (±SD) at diagnosis for the case and control groups were 11.07 weeks (±0.95, range 10–13 weeks) and 11.51 weeks (±1.04, range 10–13 weeks), respectively. Procedural fetal loss rates were evaluated in these groups after follow-up until 28 weeks of gestation. Results: The average hematoma volume (±SD) was 1.83 ml (±1.57, range 0.3–10.0 ml). Post-CVS early fetal loss was seen in 3.57% (2/56) of patients in the case group and 1.62% (16/986) of patients in the control group. Late fetal loss (up to the 28th week) in the case and control groups was 8.16% (4/49) and 3.76% (29/771), respectively. Post-CVS early fetal loss was seen in 2.44% (1/41) of patients with small-sized SCH (Conclusion: We were unable to detect any statistically significant difference in fetal loss rate after performing CVS in patients with SCH in comparison to the control group. However, it seems that fetal loss rate may be higher in the presence of medium-sized (20–50% of gestational sac circumference) SCH and further cases are necessary to evaluate the safety of doing CVS in this group.
    No preview · Article · Aug 2007 · Fetal Diagnosis and Therapy
Show more